Akers Biosciences Inc (AKER):企業の財務・戦略的SWOT分析

◆英語タイトル:Akers Biosciences Inc (AKER) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME282FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. The company provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell separation, and synthetic macrocycle complex. The company serves medical clinicians, individuals, corporations, and law enforcement agencies, health professionals. ABI is headquartered in West Deptford, New Jersey, the US.

Akers Biosciences Inc Key Recent Developments

Mar 22,2021: Akers Biosciences announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals
Feb 19,2021: New study shows correlation between temperature and Covid-19 transmission
Jan 28,2021: Akers Biosciences announces management change
Nov 20,2020: Akers Biosciences announces appointment of Joshua Silverman
Apr 06,2020: Akers Biosciences and Premas Biotech announce progress in its vaccine development for covid-19

This comprehensive SWOT profile of Akers Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Akers Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Akers Biosciences Inc – Key Information
Akers Biosciences Inc – Overview
Akers Biosciences Inc – Key Employees
Akers Biosciences Inc – Key Employee Biographies
Akers Biosciences Inc – Key Operational Heads
Akers Biosciences Inc – Major Products and Services
Akers Biosciences Inc – History
Akers Biosciences Inc – Company Statement
Akers Biosciences Inc – Locations And Subsidiaries
Akers Biosciences Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Akers Biosciences Inc – Business Description
Akers Biosciences Inc – Corporate Strategy
Akers Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Akers Biosciences Inc – Strengths
Akers Biosciences Inc – Weaknesses
Akers Biosciences Inc – Opportunities
Akers Biosciences Inc – Threats
Akers Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Akers Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Akers Biosciences Inc, Key Information
Akers Biosciences Inc, Key Ratios
Akers Biosciences Inc, Share Data
Akers Biosciences Inc, Major Products and Services
Akers Biosciences Inc, History
Akers Biosciences Inc, Key Employees
Akers Biosciences Inc, Key Employee Biographies
Akers Biosciences Inc, Key Operational Heads
Akers Biosciences Inc, Other Locations
Akers Biosciences Inc, Subsidiaries
Akers Biosciences Inc, Key Competitors
Akers Biosciences Inc, SWOT Analysis
Akers Biosciences Inc, Ratios based on current share price
Akers Biosciences Inc, Annual Ratios
Akers Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Akers Biosciences Inc (AKER):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Dow Chemical Co (DOW)-石油・ガス分野:企業M&A・提携分析
    Summary The Dow Chemical Company (Dow) is a diversified chemical company. Its businesses encompass specialty chemicals, advanced materials, agrosciences and plastics. The company manufactures and supplies products used primarily as raw materials in the manufacture of customer products and services. …
  • OJSC Dixy Group:企業の戦略・SWOT・財務情報
    OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report Summary OJSC Dixy Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Bracco SpA:企業の戦略的SWOT分析
    Bracco SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Rexnord Corp (RXN):企業の財務・戦略的SWOT分析
    Rexnord Corp (RXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Audentes Therapeutics Inc (BOLD)-製薬・医療分野:企業M&A・提携分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myop …
  • Dragon Oil Plc:企業の戦略的SWOT分析
    Dragon Oil Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Ultimovacs AS-製薬・医療分野:企業M&A・提携分析
    Summary Ultimovacs AS (Ultimovacs) is a provider of novel immunotherapies for cancer treatment. The company develops synthetic peptide based therapeutic vaccines that can be used on its own and also in combination with conventional therapies such as surgery, chemotherapy, and irradiation. Its UV1 is …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • Clarius Group Limited (CND):企業の財務・戦略的SWOT分析
    Clarius Group Limited (CND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Noble Group Ltd:企業の戦略・SWOT・財務分析
    Noble Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Noble Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Vestas Wind Systems AS (VWS):企業の財務・戦略的SWOT分析
    Vestas Wind Systems AS (VWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • University of Leicester-製薬・医療分野:企業M&A・提携分析
    Summary University of Leicester (UOL) is an educational service provider that offers undergraduate, postgraduate, distance learning and part-time programs. The university offers educational and research services in various disciplines such as mathematics, biochemistry, medicine, astrophysics, geneti …
  • Penske Corporation:企業の戦略的SWOT分析
    Penske Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Reliance Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Reliance Life Sciences Pvt Ltd (Reliance Life Sciences) a subsidiary of Reliance Industries Limited, is a biotechnology company which manufactures and develops medical products for healthcare industry. The company’s product portfolio includes plasma proteins, biosimilars, proteins, steroid, …
  • Adtran Inc (ADTN):企業の財務・戦略的SWOT分析
    Adtran Inc (ADTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ProMetic Life Sciences Inc (PLI):企業の財務・戦略的SWOT分析
    ProMetic Life Sciences Inc (PLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Astellas Pharma Inc.:企業の戦略・SWOT・財務情報
    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report Summary Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Columbus A/S (COLUM):企業の財務・戦略的SWOT分析
    Summary Columbus A/S (Columbus), formerly Columbus IT Partner A/S, is a technology company that offers integrated business systems. The company offers digital transformation, ERP and CRM solutions and Columbus solutions. Its digital transformation solution includes cloud, mobility, e-commerce and In …
  • Tomey Corp:企業の戦略的SWOT分析
    Tomey Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆